世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

大動脈弁置換市場。世界の産業動向、シェア、サイズ、成長、機会、および2021-2026年の予測


Aortic Valve Replacement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

The global aortic valve replacement market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 11.4% during 2021-2026. Keeping in mind the... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス
2021年11月10日 US$2,299
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
145 英語

 

サマリー

The global aortic valve replacement market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 11.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Aortic valve replacement is a procedure to treat diseases affecting the valves that control blood flow through the heart. It helps restore normal blood flow, reduce symptoms, prolong life, and preserve the function of the heart muscle. It is usually performed through the traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter inserted in the leg. Nowadays, leading players are introducing artificial valves, which are made using carbon-coated plastic or tissue from cows, pigs, or donors.

Aortic Valve Replacement Market Trends:
In confluence with the increasing demand for MIS, the growing prevalence of valvular diseases represents one of the key factors stimulating the market growth. Moreover, governments of numerous countries are undertaking various initiatives for managing valvular diseases, which, in turn, is driving the market. Apart from this, as valves become narrow and stiff from aging, the growing geriatric population is contributing to market growth. The favorable reimbursement policies in hospitals are also influencing the market. Furthermore, the increasing number of approvals for innovative products is anticipated to bolster the market growth. For instance, JenaValve Technology, Inc., a developer and manufacturer of transcatheter aortic valve replacement (TAVR) system, received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) in 2020. This designation is for severe aortic regurgitation (AR) and AR dominant mixed aortic valve disease, which is a life-threatening and seriously debilitating condition in patients.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global aortic valve replacement market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, surgery, product and end use.

Breakup by Surgery:

Open Surgery
Minimally Invasive Surgery

Breakup by Product:

Transcatheter Aortic Valve
Sutureless Valve
Others

Breakup by End Use:

Hospitals
Ambulatory Surgery Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corporation, Coroneo Inc., CryoLife Inc., Edward Lifesciences Corporation, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medtronic plc and Thubrikar Aortic Valve Inc. Key Questions Answered in This Report:
How has the global aortic valve replacement market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global aortic valve replacement market?
What are the key regional markets?
What is the breakup of the market based on the surgery?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global aortic valve replacement market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る


目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Aortic Valve Replacement Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Surgery
6.1 Open Surgery
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Minimally Invasive Surgery
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product
7.1 Transcatheter Aortic Valve
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Sutureless Valve
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Anteris Technologies Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Coroneo Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 CryoLife Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Edward Lifesciences Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 JenaValve Technology Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 LifeNet Health Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 LivaNova PLC
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Medtronic plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thubrikar Aortic Valve Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio

 

ページTOPに戻る


 

Summary

The global aortic valve replacement market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 11.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Aortic valve replacement is a procedure to treat diseases affecting the valves that control blood flow through the heart. It helps restore normal blood flow, reduce symptoms, prolong life, and preserve the function of the heart muscle. It is usually performed through the traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter inserted in the leg. Nowadays, leading players are introducing artificial valves, which are made using carbon-coated plastic or tissue from cows, pigs, or donors.

Aortic Valve Replacement Market Trends:
In confluence with the increasing demand for MIS, the growing prevalence of valvular diseases represents one of the key factors stimulating the market growth. Moreover, governments of numerous countries are undertaking various initiatives for managing valvular diseases, which, in turn, is driving the market. Apart from this, as valves become narrow and stiff from aging, the growing geriatric population is contributing to market growth. The favorable reimbursement policies in hospitals are also influencing the market. Furthermore, the increasing number of approvals for innovative products is anticipated to bolster the market growth. For instance, JenaValve Technology, Inc., a developer and manufacturer of transcatheter aortic valve replacement (TAVR) system, received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) in 2020. This designation is for severe aortic regurgitation (AR) and AR dominant mixed aortic valve disease, which is a life-threatening and seriously debilitating condition in patients.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global aortic valve replacement market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, surgery, product and end use.

Breakup by Surgery:

Open Surgery
Minimally Invasive Surgery

Breakup by Product:

Transcatheter Aortic Valve
Sutureless Valve
Others

Breakup by End Use:

Hospitals
Ambulatory Surgery Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corporation, Coroneo Inc., CryoLife Inc., Edward Lifesciences Corporation, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medtronic plc and Thubrikar Aortic Valve Inc. Key Questions Answered in This Report:
How has the global aortic valve replacement market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global aortic valve replacement market?
What are the key regional markets?
What is the breakup of the market based on the surgery?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global aortic valve replacement market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る


Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Aortic Valve Replacement Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Surgery
6.1 Open Surgery
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Minimally Invasive Surgery
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product
7.1 Transcatheter Aortic Valve
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Sutureless Valve
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Anteris Technologies Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Coroneo Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 CryoLife Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Edward Lifesciences Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 JenaValve Technology Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 LifeNet Health Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 LivaNova PLC
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Medtronic plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thubrikar Aortic Valve Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/27 10:26

153.88 円

161.83 円

196.22 円

ページTOPに戻る